Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

Share Price is delayed by 15 minutes
Get Live Data
41.12    -1.44 (-3.38%)
Bid:
41.06
Ask:
43.48
Spread: 2.42 (5.894%)
Market Cap: £416.42m
AML Live PriceLast checked at - London Stock Exchange

Intraday Aston Martin Lagonda Share Chart

Additional Listing

15 Jul 2021 07:00

RNS Number : 0942F
Aston Martin Lagonda Global Hld PLC
15 July 2021
 

15 July 2021

 

 

Aston Martin Lagonda Global Holdings plc

(the "Company")

 

 

Announcement for Admission of New Shares pursuant to Warrant Instrument

 

 

In accordance with Listing Rule 9.6.4(6), the Company announces that 945,131 Ordinary Shares of £0.10 (the "Warrant Shares") each have been allotted and issued following an exercise of the Warrants constituted and issued pursuant to the Warrant Instrument executed by the Company on 7 December 2020.

 

Application has been made for the Warrant Shares to be admitted to the premium listing segment of the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange's market for listed securities. Admission is expected to take place at 8:00 a.m. on 16 July 2021.

The Company's issued share capital following admission of the Warrant Shares will consist of 115,878,718 Ordinary Shares of £0.10 each, all with voting rights. The Company holds no Ordinary Shares in treasury. The total number of voting rights following admission will be 115,878,718 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

Capitalised terms used but not otherwise defined in this announcement have the meanings given to them in the Prospectus, which is available on the Company's website (www.astonmartinlagonda.com/investors/funding/October-2020-Placing).

 

 

 

 

Enquiries:

 

Investors and Analysts

Charlotte Cowley,

Director of Investor Relations 

 

+44 (0)7771 976764

charlotte.cowley@astonmartin.com

Media

Kevin Watters,

Director of Communications

 

 

 +44 (0)7764 386683

kevin.watters@astonmartin.com

Grace Barnie,

Corporate Communications Manager

 

 +44 (0)7880 903490

grace.barnie@astonmartin.com

Tulchan Communications

Harry Cameron and Simon Pilkington

+44 (0)20 73534200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSGPUBGMUPGGGW
Date   Source Headline
29th Sep 20223:05 pmRNSDirector/PDMR Shareholding
29th Sep 20221:36 pmRNSHolding(s) in Company
29th Sep 20228:37 amRNSTender offer for portion of outstanding notes
28th Sep 202212:01 pmRNSRump Placing Announcement
28th Sep 20227:00 amRNSResults of Rights Issue and Total Voting Rights
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
15th Sep 20224:35 pmRNSPrice Monitoring Extension
14th Sep 20224:38 pmRNSHolding(s) in Company
14th Sep 20229:49 amRNSHolding(s) in Company
14th Sep 20229:46 amRNSHolding(s) in Company
14th Sep 20227:00 amRNSRights Issue offer period amended
13th Sep 20229:00 amRNSHolding(s) in Company
12th Sep 20227:00 amRNSAdmission of Nil Paid Rights
9th Sep 20227:00 amRNSAdmission of placing shares & total voting rights
8th Sep 202211:32 amRNSResult of General Meeting
5th Sep 202212:28 pmRNSPublication of Prospectus
5th Sep 20227:00 amRNS4 for 1 c.£575.8 million Rights Issue
22nd Aug 20227:00 amRNSCircular and Notice of General Meeting
29th Jul 20227:00 amRNSHalf-year Report
15th Jul 20227:00 amRNSProposed New Equity Financing and Investment
1st Jul 20223:37 pmRNSHolding(s) in Company
1st Jul 202211:38 amRNSHolding(s) in Company
30th Jun 20223:31 pmRNSStatement Regarding Media Commentary
20th Jun 20221:20 pmRNSCompany Secretary Change
14th Jun 20227:00 amRNSDirector/PDMR Shareholding
25th May 202212:04 pmRNSResult of AGM
11th May 20227:00 amRNSHolding(s) in Company
4th May 20227:01 amRNS1st Quarter Results
4th May 20227:00 amRNSAppointment of New Chief Executive Officer
3rd May 20227:00 amRNSNew Chief Financial Officer Joins Board
28th Apr 20223:14 pmRNSHolding(s) in Company
25th Apr 20222:08 pmRNSNotice of AGM
20th Apr 202212:19 pmRNSDirector Declaration
31st Mar 20227:00 amRNSDirector/PDMR Shareholding
14th Mar 20227:02 amRNSChief Financial Officer Board Appointment Date
14th Mar 20227:00 amRNSPublication of 2021 Annual Report and Accounts
28th Feb 20227:00 amRNSDirector/PDMR Shareholding
23rd Feb 20227:00 amRNSFinal Results
2nd Feb 20227:00 amRNSHolding(s) in Company
14th Jan 20227:00 amRNSDirectorate Change
7th Jan 20227:00 amRNSFY 2021 Trading Update
31st Dec 20217:00 amRNSTotal Voting Rights
21st Dec 20217:00 amRNSDirector/PDMR Shareholding
17th Dec 202110:01 amRNSDirector/PDMR Shareholding
2nd Dec 20213:07 pmRNSDirector/PDMR Shareholding
2nd Dec 20217:00 amRNSDirectorate Change
1st Dec 202110:19 amRNSAdditional Listing
29th Nov 202110:53 amRNSDirector/PDMR Shareholding
24th Nov 20212:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.